{"id":24184,"date":"2024-06-17T14:03:41","date_gmt":"2024-06-17T21:03:41","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/"},"modified":"2025-07-16T17:27:34","modified_gmt":"2025-07-17T00:27:34","slug":"amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/","title":{"rendered":"Amvuttra: La primera inyecci\u00f3n trimestral para el tratamiento de la amiloidosis hATTR"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Este medicamento recetado fue aprobado por primera vez por la FDA el 13 de junio de 2022, con base en datos de un solo <\/span><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT03759379\"><span style=\"font-weight: 400;\">ensayo cl\u00ednico<\/span><\/a><span style=\"font-weight: 400;\">, donde se administr\u00f3 a 122 pacientes con amiloidosis hereditaria mediada por transtiretina (hATTR). Los resultados del ensayo concluyeron que Amvuttra <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35875890\/\"><span style=\"font-weight: 400;\">deterioro de la neuropat\u00eda significativamente mejorado<\/span><\/a><span style=\"font-weight: 400;\"> en pacientes.<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-2f0faaa94b4923e5d5a009d7f6d68f94\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHable con un especialista sobre la asistencia con los copagos\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">Amvutra es la primera y \u00fanica inyecci\u00f3n que se administra cuatro veces al a\u00f1o para tratar la polineuropat\u00eda de la amiloidosis hATTR en pacientes adultos.&nbsp;<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#What_Is_Amvuttra_Used_To_Treat\" >\u00bfPara qu\u00e9 se utiliza el Amvuttra?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#What_Is_Hereditary_Transthyretin-Mediated_Amyloidosis_hATTR\" >\u00bfQu\u00e9 es la amiloidosis hereditaria mediada por transtiretina (hATTR)?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#How_Does_It_Work\" >\u00bfC\u00f3mo funciona?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#What_Is_the_Success_Rate\" >\u00bfCu\u00e1l es la tasa de \u00e9xito?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#Who_Can_Take_Amvuttra\" >\u00bfQui\u00e9n puede tomar Amvuttra?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#What_Is_the_Available_Dosage_Form_and_Strength\" >\u00bfCu\u00e1l es la forma farmac\u00e9utica y concentraci\u00f3n disponibles?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#How_Is_Amvuttra_Given\" >\u00bfC\u00f3mo se administra Amvuttra?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#How_Long_Does_It_Take_To_Work\" >\u00bfCu\u00e1nto tiempo tarda en hacer efecto?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#Common_Side_Effects\" >Efectos secundarios comunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#What_Precautions_Should_You_Take\" >\u00bfQu\u00e9 precauciones debes tomar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#What_Important_Things_Should_You_Know_About_Amvuttra\" >\u00bfQu\u00e9 cosas importantes debes saber sobre Amvuttra?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#Is_Amvuttra_a_Type_of_Gene_Therapy\" >\u00bfEs Amvuttra un tipo de terapia gen\u00e9tica?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#Cost\" >Costo<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#Drug_Summary\" >Resumen del medicamento<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Amvuttra_Used_To_Treat\"><\/span>\u00bfPara qu\u00e9 se utiliza el Amvuttra?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Amvuttra se utiliza para tratar el da\u00f1o nervioso (polineuropat\u00eda) causado por una enfermedad hATTR.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Hereditary_Transthyretin-Mediated_Amyloidosis_hATTR\"><\/span>\u00bfQu\u00e9 es la amiloidosis hereditaria mediada por transtiretina (hATTR)?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">La hATTR es un trastorno poco com\u00fan pero debilitante que afecta a m\u00faltiples \u00f3rganos y tejidos del cuerpo, incluyendo los sistemas nervioso, card\u00edaco y gastrointestinal. Esta enfermedad se produce debido a mutaciones en el gen <\/span><a href=\"https:\/\/medlineplus.gov\/genetics\/gene\/ttr\/\"><span style=\"font-weight: 400;\">transtiretina (<\/span><span style=\"font-weight: 400;\">TTR<\/span><span style=\"font-weight: 400;\">) gen<\/span><\/a><span style=\"font-weight: 400;\">, que normalmente codifica una prote\u00edna llamada transtiretina (TTR).&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">El h\u00edgado produce principalmente prote\u00edna TRR, que circula en la sangre para transportar la hormona tiroidea (tiroxina) y vitamina A (retinol) por todo el cuerpo.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Sin embargo, las mutaciones en el gen TTR hacen que el h\u00edgado produzca prote\u00ednas TTR anormales, defectuosas y que se descomponen f\u00e1cilmente. Las prote\u00ednas descompuestas se agrupan y forman... <\/span><b>dep\u00f3sitos de amiloide<\/b><span style=\"font-weight: 400;\">Los dep\u00f3sitos de amiloide, cuando se acumulan en diferentes partes del cuerpo, causan da\u00f1os a los \u00f3rganos y nervios, espec\u00edficamente a los nervios perif\u00e9ricos.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_It_Work\"><\/span>\u00bfC\u00f3mo funciona?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Amvuttra contiene un componente activo, vutrisiran, que es un tipo de <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5542916\/\"><span style=\"font-weight: 400;\">\u00e1cido ribonucleico interferente peque\u00f1o<\/span><\/a><span style=\"font-weight: 400;\">&nbsp;(siRNA). El siRNA es un fragmento corto de material gen\u00e9tico dise\u00f1ado para unirse y detener el gen TRR mutado, responsable de la producci\u00f3n de la prote\u00edna TRR.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Esto reduce significativamente la producci\u00f3n de prote\u00edna TRR defectuosa, lo que resulta en una menor formaci\u00f3n de dep\u00f3sitos amiloides.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_the_Success_Rate\"><\/span>\u00bfCu\u00e1l es la tasa de \u00e9xito?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Seg\u00fan los ensayos cl\u00ednicos, Amvuttra significativamente <\/span><a href=\"https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trial-snapshots-amvuttra\"><span style=\"font-weight: 400;\">mejora de la funci\u00f3n nerviosa y la fuerza muscular<\/span><\/a><span style=\"font-weight: 400;\"> En pacientes que tomaron el medicamento, en comparaci\u00f3n con quienes no lo tomaron. Los pacientes que toman este medicamento pueden experimentar una mejora en la velocidad al caminar, la salud nutricional y la capacidad para realizar actividades cotidianas.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_Can_Take_Amvuttra\"><\/span>\u00bfQui\u00e9n puede tomar Amvuttra?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Los pacientes con amiloidosis hATTR por polineuropat\u00eda (da\u00f1o nervioso) en estadio I y estadio II pueden tomar Amvuttra.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">El da\u00f1o nervioso en etapa I es cuando el paciente siente debilidad en las piernas pero puede caminar sin ayuda.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">En el da\u00f1o nervioso en estadio II, el paciente a\u00fan puede caminar pero necesita apoyo.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Los pacientes cuya enfermedad progresa a la etapa III a\u00fan pueden tomar este medicamento si los beneficios superan los riesgos.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_the_Available_Dosage_Form_and_Strength\"><\/span>\u00bfCu\u00e1l es la forma farmac\u00e9utica y concentraci\u00f3n disponibles?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El Amvuttra est\u00e1 disponible en una jeringa precargada de dosis \u00fanica de 25 mg\/0,5 ml. Solo se puede obtener con receta m\u00e9dica.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_Amvuttra_Given\"><\/span>\u00bfC\u00f3mo se administra Amvuttra?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El Amvuttra se administra mediante inyecci\u00f3n subcut\u00e1nea (bajo la piel) una vez cada tres meses por un profesional de la salud experimentado. Generalmente se inyecta alrededor del abdomen, los muslos o la parte superior del brazo.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Long_Does_It_Take_To_Work\"><\/span>\u00bfCu\u00e1nto tiempo tarda en hacer efecto?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Tras la primera dosis, Amvuttra comienza a disminuir la prote\u00edna TTR, y este efecto persiste mientras se mantenga el tratamiento. En un estudio cl\u00ednico con personas tratadas con Amvuttra, el 48% de los pacientes recuper\u00f3 parte de su funci\u00f3n nerviosa a los 18 meses.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Common_Side_Effects\"><\/span>Efectos secundarios comunes<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/amvuttra-side-effects.jpg\" alt=\"Old man suffering from side effects of Amvuttra\" class=\"wp-image-24187\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/amvuttra-side-effects.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/amvuttra-side-effects-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/amvuttra-side-effects-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/amvuttra-side-effects-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/amvuttra-side-effects-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/amvuttra-side-effects-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/amvuttra-side-effects-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">El Amvuttra tambi\u00e9n presenta algunos efectos secundarios, adem\u00e1s de sus posibles beneficios. Los efectos secundarios m\u00e1s comunes, observados en m\u00e1s del 51% de los pacientes tras tomar el medicamento, incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Dolor en las extremidades (brazos y piernas)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Artralgia (dolor articular)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dificultad para respirar (disnea)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">niveles bajos de vitamina A<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Precautions_Should_You_Take\"><\/span>\u00bfQu\u00e9 precauciones debes tomar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Antes de tomar Amvuttra, es importante consultar con su profesional de la salud y compartir su estado de salud actual e historial m\u00e9dico. Aseg\u00farese de informar a su m\u00e9dico si:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><b>Embarazada o con intenci\u00f3n de quedar embarazada:<\/b><span style=\"font-weight: 400;\"> Dado que no hay datos disponibles sobre los efectos de Amvuttra en un beb\u00e9 nonato, es importante consultar a su proveedor de atenci\u00f3n m\u00e9dica antes de tomar Amvuttra.<\/span><\/li>\n\n\n\n<li><b>Amamantamiento:<\/b><span style=\"font-weight: 400;\"> No est\u00e1 claro si Amvuttra pasa a la leche materna; por lo tanto, debe evitar tomarlo si est\u00e1 amamantando.<\/span><\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-2776dd40520737213bbc52946b6a5336\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Important_Things_Should_You_Know_About_Amvuttra\"><\/span>\u00bfQu\u00e9 cosas importantes debes saber sobre Amvuttra?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El Amvuttra puede causar niveles bajos de vitamina A. Como se mencion\u00f3 anteriormente, la prote\u00edna TRR es responsable del transporte de retinol (vitamina A) a trav\u00e9s del cuerpo. Tomar Amvuttra puede reducir significativamente la cantidad de vitamina A en la sangre.&nbsp;<\/span><br><span style=\"font-weight: 400;\">La deficiencia grave de vitamina A puede provocar problemas de visi\u00f3n (p. ej., ceguera nocturna). Por lo tanto, es importante tomar suplementos de vitamina A en dosis de 2500 a 3000 UI al d\u00eda.&nbsp;<\/span><br>&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Is_Amvuttra_a_Type_of_Gene_Therapy\"><\/span>\u00bfEs Amvuttra un tipo de terapia gen\u00e9tica?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">S\u00ed, lo es <\/span><a href=\"https:\/\/arci.org\/fda-approves-amvuttra\/#:~:text=AMVUTTRATM%20is%20classified%20as,build%2Dup%20and%20organ%20damage.\"><span style=\"font-weight: 400;\">categorizado como silenciador gen\u00e9tico<\/span><\/a><span style=\"font-weight: 400;\"> que previene la acumulaci\u00f3n de amiloide y el da\u00f1o org\u00e1nico al limitar la capacidad del h\u00edgado para producir la prote\u00edna transtiretina (TTR) defectuosa. Esto resulta en niveles m\u00e1s bajos de TTR en todo el cuerpo.<\/span><br>&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span>Costo<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El costo puede ser considerablemente alto para algunos pacientes. Para una soluci\u00f3n subcut\u00e1nea (25 mg\/0,5 ml), el Amvuttra cuesta aproximadamente $125.686 por un suministro de 0,5 ml.&nbsp;<\/span><br><span style=\"font-weight: 400;\">Adem\u00e1s, si tiene intenci\u00f3n de recibir <\/span><span style=\"font-weight: 400;\">tratamiento durante un a\u00f1o, podr\u00eda<\/span><span style=\"font-weight: 400;\"> te costar\u00e1 <\/span><span style=\"font-weight: 400;\">alrededor de $572,164.<\/span><br><span style=\"font-weight: 400;\">El costo del Amvuttra puede variar seg\u00fan la farmacia que visite. Sin embargo, si est\u00e1 considerando el Amvuttra, es recomendable consultar con su profesional de la salud sobre posibles programas de asistencia que puedan ayudarle a reducir sus gastos de bolsillo. <\/span><a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\"><span style=\"font-weight: 400;\">Contacto AmeriPharma<\/span><\/a><span style=\"font-weight: 400;\"> Si est\u00e1 interesado en explorar opciones de asistencia financiera.<\/span><br>&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Drug_Summary\"><\/span>Resumen del medicamento<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El Amvuttra es un f\u00e1rmaco utilizado para tratar el da\u00f1o nervioso (polineuropat\u00eda) causado por la enfermedad hATTR. El objetivo de este medicamento es prevenir la producci\u00f3n de la prote\u00edna TRR defectuosa, reduciendo as\u00ed la formaci\u00f3n de dep\u00f3sitos de amiloide en nervios y \u00f3rganos. Los niveles bajos de vitamina A y el dolor en piernas y brazos son algunos efectos secundarios comunes del Amvuttra y pueden tratarse.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Amvuttra (Vutrisiran) es el nombre comercial de un medicamento con receta llamado vutrisiran. Generalmente se receta para tratar la polineuropat\u00eda (da\u00f1o multinervioso) causada por una afecci\u00f3n llamada amiloidosis hereditaria mediada por transtiretina (hATTR) en pacientes adultos.&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-8c35da7917d69bed75c6ec31bcd70969\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHable con un especialista sobre la asistencia con los copagos\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Amvuttra (Vutrisiran) es el nombre comercial de un medicamento con receta llamado vutrisiran. Generalmente se receta para tratar la polineuropat\u00eda (da\u00f1o multinervioso) causada por una afecci\u00f3n llamada amiloidosis hereditaria mediada por transtiretina (hATTR) en pacientes adultos.\u00a0<\/p>","protected":false},"author":7,"featured_media":26029,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[4],"tags":[8],"class_list":["post-24184","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other-health-conditions","tag-dr-christine-leduc"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Amvuttra: The First Quarterly Injection for Treating hATTR Amyloidosis<\/title>\n<meta name=\"description\" content=\"Learn about how Amvuttra treats hATTR amyloidosis. Topics include how the medication works, dosage, side effects, cost, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amvuttra: The First Quarterly Injection for Treating hATTR Amyloidosis\" \/>\n<meta property=\"og:description\" content=\"Learn about how Amvuttra treats hATTR amyloidosis. Topics include how the medication works, dosage, side effects, cost, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-17T21:03:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-17T00:27:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Christine Leduc, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Christine Leduc, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/\"},\"author\":{\"name\":\"Dr. Christine Leduc, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\"},\"headline\":\"Amvuttra: The First Quarterly Injection for Treating hATTR Amyloidosis\",\"datePublished\":\"2024-06-17T21:03:41+00:00\",\"dateModified\":\"2025-07-17T00:27:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/\"},\"wordCount\":974,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/hATTR-patient-1.jpg\",\"keywords\":[\"Dr. Christine Leduc\"],\"articleSection\":[\"Other Health Conditions\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/\",\"name\":\"Amvuttra: The First Quarterly Injection for Treating hATTR Amyloidosis\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/hATTR-patient-1.jpg\",\"datePublished\":\"2024-06-17T21:03:41+00:00\",\"dateModified\":\"2025-07-17T00:27:34+00:00\",\"description\":\"Learn about how Amvuttra treats hATTR amyloidosis. Topics include how the medication works, dosage, side effects, cost, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/hATTR-patient-1.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/hATTR-patient-1.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Young doctor asking senior impaired male patient in wheelchair to sign insurance policy at home. Handicapped elderly man putting his signature under surgery consent form, reading medical document\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/other-health-conditions\\\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amvuttra: The First Quarterly Injection for Treating hATTR Amyloidosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/0d161a7a3c2b0cf54ab0cf25c936dd87\",\"name\":\"Dr. Christine Leduc, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g\",\"caption\":\"Dr. Christine Leduc, PharmD\"},\"description\":\"Dr. Christine Leduc, PharmD, was born and raised in Irvine, CA. She attended college at Midwestern University, where she graduated cum laude. The most rewarding part of her job is suggesting lifestyle changes, educating patients on how their medication works, and precepting future pharmacists. Her areas of expertise are customer service and knowledge of specialty medication. Having worked in the service industry in the past, she has gained the customer service skills necessary to understand the needs of her patients. Dr. Leduc is currently precepting students from Marshall B. Ketchum University, University of Kansas, and Midwestern University. In her free time, she enjoys traveling, baking, and gardening. See Author Biography\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/christine-leduc\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amvuttra: La primera inyecci\u00f3n trimestral para el tratamiento de la amiloidosis hATTR","description":"Aprenda c\u00f3mo Amvuttra trata la amiloidosis hATTR. Los temas incluyen c\u00f3mo funciona el medicamento, la dosis, los efectos secundarios, el costo y m\u00e1s.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/","og_locale":"es_MX","og_type":"article","og_title":"Amvuttra: The First Quarterly Injection for Treating hATTR Amyloidosis","og_description":"Learn about how Amvuttra treats hATTR amyloidosis. Topics include how the medication works, dosage, side effects, cost, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2024-06-17T21:03:41+00:00","article_modified_time":"2025-07-17T00:27:34+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg","type":"image\/jpeg"}],"author":"Dr. Christine Leduc, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Christine Leduc, PharmD","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/"},"author":{"name":"Dr. Christine Leduc, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87"},"headline":"Amvuttra: The First Quarterly Injection for Treating hATTR Amyloidosis","datePublished":"2024-06-17T21:03:41+00:00","dateModified":"2025-07-17T00:27:34+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/"},"wordCount":974,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg","keywords":["Dr. Christine Leduc"],"articleSection":["Other Health Conditions"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/","url":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/","name":"Amvuttra: La primera inyecci\u00f3n trimestral para el tratamiento de la amiloidosis hATTR","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg","datePublished":"2024-06-17T21:03:41+00:00","dateModified":"2025-07-17T00:27:34+00:00","description":"Aprenda c\u00f3mo Amvuttra trata la amiloidosis hATTR. Los temas incluyen c\u00f3mo funciona el medicamento, la dosis, los efectos secundarios, el costo y m\u00e1s.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg","width":1280,"height":853,"caption":"Young doctor asking senior impaired male patient in wheelchair to sign insurance policy at home. Handicapped elderly man putting his signature under surgery consent form, reading medical document"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/amvuttra-the-first-quarterly-injection-for-treating-hattr-amyloidosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"Amvuttra: The First Quarterly Injection for Treating hATTR Amyloidosis"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/0d161a7a3c2b0cf54ab0cf25c936dd87","name":"Dra. Christine Leduc, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f2e7e868ac19420a5672d88350e7e0e3c6a750140410fd606eec96984812e89?s=96&d=mm&r=g","caption":"Dr. Christine Leduc, PharmD"},"description":"La Dra. Christine Leduc, doctora en farmacia, naci\u00f3 y creci\u00f3 en Irvine, California. Curs\u00f3 estudios universitarios en la Universidad Midwestern, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es sugerir cambios en el estilo de vida, educar a los pacientes sobre el funcionamiento de sus medicamentos y ser tutora de futuros farmac\u00e9uticos. Sus \u00e1reas de especializaci\u00f3n son la atenci\u00f3n al cliente y el conocimiento de medicamentos especializados. Tras haber trabajado en el sector servicios, ha adquirido las habilidades de atenci\u00f3n al cliente necesarias para comprender las necesidades de sus pacientes. Actualmente, la Dra. Leduc imparte clases a estudiantes de la Universidad Marshall B. Ketchum, la Universidad de Kansas y la Universidad Midwestern. En su tiempo libre, disfruta de viajar, la reposter\u00eda y la jardiner\u00eda. Ver biograf\u00eda de la autora.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"uagb_comment_info":0,"uagb_excerpt":"Amvuttra (Vutrisiran) is a brand name for a prescription drug called vutrisiran. It is typically prescribed to treat polyneuropathy (multiple nerve damage) caused by a condition called hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/06\/hATTR-patient-1.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Christine Leduc, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/christine-leduc\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/other-health-conditions\/\" rel=\"category tag\">Other Health Conditions<\/a>","rttpg_excerpt":"Amvuttra (Vutrisiran) is a brand name for a prescription drug called vutrisiran. It is typically prescribed to treat polyneuropathy (multiple nerve damage) caused by a condition called hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/24184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=24184"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/24184\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/26029"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=24184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=24184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=24184"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}